JPRN-UMIN000000809已完成2 期
Phase II study of hepatic arterial infusion of cisplatin for unresectable intrahepatic cholangiocarcinoma - ICC-CDDP
Division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East0 个研究点目标入组 35 人开始时间: 2007年8月31日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) presence of uncontrollable ascites or pleural effusion 2) cerebral or bone metastasis 3) uncontrollable cardiovascular disease or prior myocardial infarction 4) active infection other than HBV or HCV 5) other malignancy 6) severe psychiatric disorder 7) severe drug allergy 8) pregnant or nursing
研究者
相似试验
已完成
1 期
A phase I,II trial of hepatic arterial infusion chemotherapy with cisplatin and 5-fluorouracil for unresectable advanced hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000013734Sapporo Medical University School of Medicine28
已完成
不适用
Clinical trial of hepatic arterial infusion chemotherapy with multidrug resistance-associated protein 3-derived peptide for hepatocellular carcinomaHepatocellular carcinoma (HCC)JPRN-UMIN000005678Department of Gastroenterology, Kanazawa University Hospital12
已完成
2 期
A phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosisJPRN-UMIN000000488Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital25
已完成
不适用
Pilot study of hepatic arterial infusion chemotherapy followed by sorafenib for advanced hepatocellular carcinomaadvanced hepatocellular carcinomaJPRN-UMIN000009094Department of Gastroenterology and Metabolism,Hiroshima University Hospital55
已完成
1 期
A phase 1 trial of hepatic arterial infusion chemotherapy with high dose cisplatin and 5-fluorouracil for unresectable advanced and recurrent hepatocellular carcinomaJPRN-UMIN000015101Keio University, School of medicine, Department of Surgery18